Acadia Healthcare Reports 78.1% Growth in Second Quarter Adjusted EPS to $0.57
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Acadia Healthcare (ACHC) PT Raised to $90 at UBS on Emerging Substance Abuse Opportunity in the UK
August 6, 2015 8:17 AM EDTUBS analyst A.J. Rice reiterated a Buy rating and raised his price target on Acadia Healthcare (NASDAQ: ACHC) to $90.00 (from $85.00) following Q2 results as they see emerging substance abuse opportunity in the UK.
Rice commented, "ACHC announced the acquisition of a 15-bed... More
Acadia Healthcare (ACHC) Tops Q2 EPS by 5c, Raises FY EPS Guidance
August 4, 2015 5:44 PM EDTAcadia Healthcare (NASDAQ: ACHC) reported Q2 EPS of $0.57, $0.05 better than the analyst estimate of $0.52. Revenue for the quarter came in at $453.7 million versus the consensus estimate of $433.84 million.
Acadia Healthcare sees FY2015 EPS of $2.15-$2.18, versus prior guidance of $2.12-$2.15 and the consensus of... More
